Variant report
Variant | esv1010378 |
---|---|
Chromosome Location | chr19:51401144-51403251 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:64)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr19:51399738-51401225 | GM12878 | blood: | n/a | n/a |
2 | CBX3 | chr19:51402901-51403221 | K562 | blood: | n/a | n/a |
3 | CBX3 | chr19:51402777-51403266 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr19:51400913-51401149 | A549 | lung: | n/a | n/a |
5 | CHD1 | chr19:51399763-51401491 | GM12878 | blood: | n/a | n/a |
6 | CHD2 | chr19:51399758-51401200 | GM12878 | blood: | n/a | n/a |
7 | CTCF | chr19:51401020-51401170 | GM12865 | blood: | n/a | n/a |
8 | CTCF | chr19:51401060-51401210 | GM12867 | blood: | n/a | n/a |
9 | CTCF | chr19:51401060-51401210 | HCT-116 | colon: | n/a | n/a |
10 | CTCF | chr19:51400828-51401197 | GM12878 | blood: | n/a | n/a |
11 | CTCF | chr19:51400870-51401314 | HCT-116 | colon: | n/a | n/a |
12 | CTCF | chr19:51401000-51401150 | GM12873 | blood: | n/a | n/a |
13 | CTCF | chr19:51400926-51401271 | MCF-7 | breast: | n/a | n/a |
14 | EBF1 | chr19:51400437-51401179 | GM12878 | blood: | n/a | n/a |
15 | EBF1 | chr19:51399732-51401194 | GM12878 | blood: | n/a | n/a |
16 | EBF1 | chr19:51399721-51401233 | GM12878 | blood: | n/a | n/a |
17 | ELF1 | chr19:51402865-51403200 | K562 | blood: | n/a | chr19:51403060-51403073 |
18 | EP300 | chr19:51399746-51401224 | GM12878 | blood: | n/a | chr19:51400074-51400083 |
19 | EP300 | chr19:51399719-51401397 | GM12878 | blood: | n/a | chr19:51400074-51400083 |
20 | FAM48A | chr19:51401955-51402133 | GM12878 | blood: | n/a | n/a |
21 | GABPA | chr19:51402796-51403227 | HL-60 | blood: | n/a | n/a |
22 | GABPA | chr19:51402984-51403133 | HepG2 | liver: | n/a | n/a |
23 | GABPA | chr19:51403000-51403116 | HepG2 | liver: | n/a | n/a |
24 | GABPA | chr19:51402856-51403249 | MCF-7 | breast: | n/a | n/a |
25 | GABPA | chr19:51402812-51403257 | MCF-7 | breast: | n/a | n/a |
26 | GABPA | chr19:51402784-51403248 | SK-N-SH | brain: | n/a | n/a |
27 | GABPA | chr19:51402929-51403172 | Hela-S3 | cervix: | n/a | n/a |
28 | GABPA | chr19:51402705-51403209 | A549 | lung: | n/a | n/a |
29 | GABPA | chr19:51402837-51403221 | Hela-S3 | cervix: | n/a | n/a |
30 | GABPA | chr19:51402712-51403256 | HL-60 | blood: | n/a | n/a |
31 | GABPA | chr19:51402791-51402895 | Hela-S3 | cervix: | n/a | n/a |
32 | GABPA | chr19:51402665-51403248 | A549 | lung: | n/a | n/a |
33 | GABPA | chr19:51402834-51403244 | SK-N-SH | brain: | n/a | n/a |
34 | GABPA | chr19:51402925-51403214 | K562 | blood: | n/a | n/a |
35 | HCFC1 | chr19:51402890-51403182 | K562 | blood: | n/a | n/a |
36 | IKZF1 | chr19:51399524-51401263 | GM12878 | blood: | n/a | n/a |
37 | JUND | chr19:51399790-51401173 | GM12878 | blood: | n/a | chr19:51400073-51400083 chr19:51400073-51400083 chr19:51400072-51400084 chr19:51400073-51400083 chr19:51400072-51400083 chr19:51400031-51400040 chr19:51400073-51400082 |
38 | MAFF | chr19:51402334-51402448 | K562 | blood: | n/a | n/a |
39 | MAFK | chr19:51402280-51402535 | HepG2 | liver: | n/a | n/a |
40 | MAFK | chr19:51402347-51402526 | HepG2 | liver: | n/a | n/a |
41 | MAFK | chr19:51403019-51403199 | K562 | blood: | n/a | n/a |
42 | MTA3 | chr19:51399656-51401174 | GM12878 | blood: | n/a | n/a |
43 | NFIC | chr19:51399736-51401276 | GM12878 | blood: | n/a | n/a |
44 | NR2C2 | chr19:51402816-51403235 | Hela-S3 | cervix: | n/a | n/a |
45 | POLR2A | chr19:51401226-51401240 | GM12878 | blood: | n/a | n/a |
46 | RAD21 | chr19:51400947-51401147 | Hela-S3 | cervix: | n/a | n/a |
47 | RAD21 | chr19:51400904-51401145 | GM12878 | blood: | n/a | n/a |
48 | RAD21 | chr19:51400834-51401244 | MCF-7 | breast: | n/a | n/a |
49 | RAD21 | chr19:51400829-51401355 | HCT-116 | colon: | n/a | n/a |
50 | RCOR1 | chr19:51401337-51401670 | K562 | blood: | n/a | n/a |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:51306246..51308382-chr19:51400037..51401731,2 | K562 | blood: | |
2 | chr19:51297092..51299196-chr19:51400128..51402648,2 | K562 | blood: | |
3 | chr19:51398902..51402347-chr19:51410482..51413710,3 | K562 | blood: | |
4 | chr19:51398615..51401717-chr19:51409067..51411982,3 | K562 | blood: | |
5 | chr19:51402463..51404550-chr19:51522904..51525156,2 | MCF-7 | breast: | |
6 | chr19:51391887..51394090-chr19:51400649..51402810,2 | MCF-7 | breast: | |
7 | chr19:51305899..51307746-chr19:51399929..51401731,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KLKP1 | TF binding region |
ENSG00000167747 | chromatin interactions |
ENSG00000129451 | chromatin interactions |
ENSG00000197588 | chromatin interactions |
ENSG00000167749 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374488405 | chr19:51401202-51401203 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
2 | rs537386122 | chr19:51401204-51401205 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs142463956 | chr19:51401290-51401291 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
4 | rs200932982 | chr19:51401301-51401302 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
5 | rs374047430 | chr19:51401383-51401384 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
6 | rs573829442 | chr19:51401392-51401393 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
7 | rs10409668 | chr19:51401401-51401402 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs552994055 | chr19:51401467-51401468 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
9 | rs577320004 | chr19:51401470-51401471 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
10 | rs567187912 | chr19:51401506-51401507 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs183457454 | chr19:51401517-51401518 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs150896065 | chr19:51401528-51401529 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs574343756 | chr19:51401561-51401562 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs575514576 | chr19:51401564-51401565 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs543055689 | chr19:51401608-51401609 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs188115696 | chr19:51401617-51401618 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs372064161 | chr19:51401641-51401642 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs7250437 | chr19:51401656-51401657 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs139718345 | chr19:51401676-51401677 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs532670463 | chr19:51401692-51401693 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs375995287 | chr19:51401739-51401740 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs115887456 | chr19:51401744-51401745 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs569303003 | chr19:51401776-51401777 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs8104538 | chr19:51401797-51401798 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs3875143 | chr19:51401807-51401808 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs567460263 | chr19:51401809-51401810 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs534766123 | chr19:51401865-51401866 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs76732076 | chr19:51401927-51401928 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs529193085 | chr19:51401955-51401956 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs116777269 | chr19:51401960-51401961 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs547263579 | chr19:51401968-51401969 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs556073805 | chr19:51401988-51401989 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs559152073 | chr19:51401989-51401990 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
34 | rs202004564 | chr19:51401997-51401998 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs556515934 | chr19:51402021-51402022 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs563335430 | chr19:51402040-51402041 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
37 | rs113835397 | chr19:51402058-51402059 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs112321301 | chr19:51402066-51402067 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs542942919 | chr19:51402084-51402085 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs555203471 | chr19:51402085-51402086 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs532238013 | chr19:51402087-51402088 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs540787936 | chr19:51402098-51402099 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs575357174 | chr19:51402112-51402113 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs115037353 | chr19:51402222-51402223 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs532947421 | chr19:51402233-51402234 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs532630700 | chr19:51402248-51402249 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs191783006 | chr19:51402251-51402252 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs562863689 | chr19:51402265-51402266 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs368943230 | chr19:51402346-51402347 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs552350101 | chr19:51402391-51402392 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Colorectal cancer | 16272173 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:51399400-51401400 | Enhancers | Primary B cells from peripheral blood | blood |
2 | chr19:51399800-51401400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr19:51399800-51401600 | Enhancers | HMEC | breast |
4 | chr19:51399800-51403000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr19:51400600-51402800 | Weak transcription | K562 | blood |
6 | chr19:51401000-51401600 | Enhancers | GM12878-XiMat | blood |
7 | chr19:51401400-51402600 | Weak transcription | Primary B cells from peripheral blood | blood |
8 | chr19:51401600-51402400 | Weak transcription | GM12878-XiMat | blood |
9 | chr19:51402400-51403200 | Enhancers | GM12878-XiMat | blood |
10 | chr19:51402600-51402800 | Enhancers | Primary B cells from peripheral blood | blood |
11 | chr19:51402800-51403200 | Enhancers | K562 | blood |